SCHLACKMAN SCOTT

MED

SCHLACKMAN SCOTT serves as director at Medifast, Inc. (MED). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

6 trades

$73.3K

Total Sells

3 trades

$709.2K

Net Position

Net Seller

$635.9K

Companies Traded

MED

Active Period

May 2021 – May 2026

9 total trades

Most Recent

Buy MED

May 12, 2026 · $63.0K

SCHLACKMAN SCOTT's Insider Trading at Medifast, Inc. (MED)

Buys

6 · $73.3K

Sells

3 · $709.2K

Total Shares Bought

5,123

Total Shares Sold

7,253

MED Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 12, 2026	Buy	5,000	$12.59	$63.0K	30,549
Mar 12, 2024	Sell	4,053	$39.44	$159.9K	10,538
Nov 9, 2023	Buy	52	$68.89	$3.6K	10,538
Aug 10, 2023	Buy	39	$89.42	$3.5K	10,485
May 11, 2023	Buy	13	$87.50	$1.1K	7,293
Mar 14, 2023	Sell	2,200	$108.68	$239.1K	7,280
Feb 9, 2023	Buy	9	$114.97	$1.0K	7,280
Nov 10, 2022	Buy	10	$106.93	$1.1K	7,270
May 21, 2021	Sell	1,000	$310.23	$310.2K	5,231

Related Insiders

Daniel R Chard

director, officer: Chairman & CEO

MEDBuy · Mar 27, 2026

Explore More Insider Trading Data

MED Insider Trading Activity

View all insider trades at Medifast, Inc.

Consumer Cyclical Sector Insider Trades

See insider activity across consumer cyclical stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity